Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for painful knee osteoarthritis with bone marrow lesions
ACTRN12613000039785Phase 3Completed
- Sponsor
- Menzies Institute for Medical Research
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zoledronic acid in knee osteoarthritis (OA), sponsored by Menzies Institute for Medical Research. Started Nov 2013; status: completed.
02
Drugs
zoledronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12613000039785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000039785.